Indian medical leaders are concerned about a drug alert issued by the country’s regulator listing 50 products as “not of standard quality.” The list includes various medications like vitamin C tablets, Shelcal, and paracetamol tablets manufactured by well-known companies. Other companies, like Sun Pharma and Torrent Pharma, claim that their flagged medicines are not counterfeit but meet quality standards. The regulator’s list is based on drug samples collected from the market and is meant to alert healthcare providers of potential risks associated with these products. The issue highlights the importance of ensuring the quality and reliability of medications in India’s healthcare system.
Source link
India: regulator’s list of 50 substandard drugs raises questions about oversight and manufacturing
